Olga Ulmanová

Olga Ulmanová

Auto-generated profile, based on publicly available information

Olga Ulmanová

Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Sleep Medicine
Verified
Journal Article
Closed access
JRJan Rusz
Jan Rusz
JHJan Hlavnička
Jan Hlavnička
TTTereza Tykalová
Tereza Tykalová
JBJitka Bušková
Jitka Bušková
OUOlga Ulmanová
Olga Ulmanová
KSKarel Sonka
Karel Sonka

26 April 2012 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
MHMartina Hoskovcová
Martina Hoskovcová
OUOlga Ulmanová
Olga Ulmanová
OŠOtakar Šprdlík
Otakar Šprdlík
TSTomáš Sieger
Tomáš Sieger
JNJana Nováková
Jana Nováková
EREvžen Růžička
Evžen Růžička

7 February 2013 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
PLPetra Liskova
Petra Liskova
OUOlga Ulmanova
Olga Ulmanova
PTPetr Tesina
Petr Tesina
HMHana Melsova
Hana Melsova
PDPavel Diblik
Pavel Diblik
Marcela VotrubaMarcela Votruba
Marcela Votruba
: Purpose:  To identify the underlying molecular genetic cause in a Czech family with optic atrophy, deafness, ptosis, ophthalmoplegia, polyneuropathy and ataxia transmitted as an autosomal dominant trait.Methods:  Ophthalmological and neurological examination followed by molecular genetic analyses.Results:  Seven family members were clinically affected. There was a variable but progressive visual, hearing and neurological disability across the family as a whole. The majority of subjects presented with impairment of visual function and a variable degree of ptosis and/or ophthalmoplegia from the first to the third decade of life. Deafness, neuropathy and ataxia appeared later, in the third and fourth decade. Migraine, tachycardia, intention tremor, nystagmus and cervical dystonia were observed in isolated individuals. A significant overall feature was the high level of neurological disability leading to 3 of 4 members being unable to walk or stand unaided before the age of 60 years. A novel missense mutation c.1345A>C (p.Thr449Pro) in OPA1 segregating with the disease phenotype over three generations was detected. In silico analysis supported pathogenicity of the identified sequence variant.Conclusion:  Our work expands the spectrum of mutation in OPA1, which may lead to severe multisystem neurological disorder. The molecular genetic cause of dominant optic atrophy in the Czech population is reported for the first time. We propose that regular cardiac follow‐up in patients diagnosed with dominant optic atrophy and widespread neurological disease should be considered.

1 May 2011 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
ZUZdenka Uhríková
Zdenka Uhríková
OŠOtakar Šprdlík
Otakar Šprdlík
MHMartina Hoskovcová
Martina Hoskovcová
AKArnošt Komárek
Arnošt Komárek
OUOlga Ulmanová
Olga Ulmanová
EREvžen Růžička
Evžen Růžička

5 May 2021 in Movement Disorders
Verified
Journal Article
Open access
PDF file
MZMichael Zech
Michael Zech
RJRobert Jech
Robert Jech
SBSylvia Boesch
Sylvia Boesch
MŠMatej Škorvánek
Matej Škorvánek
JNJán Necpál
Ján Necpál
KOKonrad Oexle
Konrad Oexle
Background: Despite the established value of genomic testing strategies, practice guidelines for their use do not exist in many indications.Objectives: We sought to validate a recently introduced scoring algorithm for dystonia, predicting the diagnostic utility of whole‐exome sequencing (WES) based on individual phenotypic aspects (age‐at‐onset, body distribution, presenting comorbidity).Methods: We prospectively enrolled a set of 209 dystonia‐affected families and obtained summary scores (0–5 points) according to the algorithm. Singleton (N = 146), duo (N = 11), and trio (N = 52) WES data were generated to identify genetic diagnoses.Results: Diagnostic yield was highest (51%) among individuals with a summary score of 5, corresponding to a manifestation of early‐onset segmental or generalized dystonia with coexisting non‐movement disorder‐related neurological symptoms. Sensitivity and specificity at the previously suggested threshold for implementation of WES (3 points) was 96% and 52%, with area under the curve of 0.81.Conclusions: The algorithm is a useful predictive tool and could be integrated into dystonia routine diagnostic protocols. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society

19 December 2017 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
OBO. Bartošová
O. Bartošová
CBC. Bonnet
C. Bonnet
OUO. Ulmanová
O. Ulmanová
MŠMartin Šíma
Martin Šíma
FPF. Perlík
F. Perlík
Ondřej SlanařOndřej Slanař
Ondřej Slanař